<?xml version="1.0" encoding="UTF-8"?>
<results title="migration">
 <result pre="h treatment. Further study revealed that Pra-B potently inhibited the" exact="migration" post="and invasion of 786-O and ACHN cells, as well"/>
 <result pre="are the first to demonstrate that Pra-B can reduce the" exact="migration" post="and invasion ability of human RCC cells through suppressing"/>
 <result pre="agent for the treatment of RCC. renal cell carcinoma Praeruptorin-B" exact="migration" post="invasion CTSC CTSV 1. Introduction Kidney cancer accounts for"/>
 <result pre="this study, we investigate the inhibitory effect of Pra-B on" exact="migration" post="and invasion in RCC and further identify underlying molecular"/>
 <result pre="ACHN Cells To examine the effect of Pra-B on cellular" exact="migration" post="and invasion ability in renal cell carcinoma, we treated"/>
 <result pre="increasing dose of Pra-B significantly reduced 786-O and ACHN cell" exact="migration" post="and invasion ability (Figure 2A). On the basis of"/>
 <result pre="Pra-B has an inhibitory effect on 786-O and ACHN cell" exact="migration" post="and invasion capacities. 2.3. Pra-B Inhibits the Expression of"/>
 <result pre="CTSC as being a target in the suppression of RCC" exact="migration" post="and invasion [24]. To identify the effect of Pra-B"/>
 <result pre="its molecular mechanisms involved in the regulation of tumor cell" exact="migration" post="and invasion [25]. To determine which MAPKs pathway was"/>
 <result pre="To determine which MAPKs pathway was involved in downregulating of" exact="migration" post="and invasive ability of Pra-B, we treated 786-O and"/>
 <result pre="pathways are involved in the Pra-B-mediated inhibition of human RCC" exact="migration" post="and invasion. To further determine the role of Pra-B"/>
 <result pre="invasion. To further determine the role of Pra-B in EGF-induced" exact="migration" post="and invasion of 786-O cells, we found that Pra-B"/>
 <result pre="786-O cells, we found that Pra-B significantly inhibited EGF-induced cell" exact="migration" post="of 786-O cells, compared with EGF-treated alone. Similar results"/>
 <result pre="lines (786-O and ACHN). However, Pra-B significantly inhibited RCC cells" exact="migration" post="and invasion ability as well as downregulated CTSC and"/>
 <result pre="agent through suppressing CTSC and CTSV expression as well as" exact="migration" post="and invasion through downregulating the EGFR–MEK–ERK signaling cascade in"/>
 <result pre="a series of ECM destruction leading to subsequent tumor cell" exact="migration" post="and invasion [29]. In the context of carcinogenesis, cysteine"/>
 <result pre="and inducing CTSD may facilitate breast and gastric cancer cell" exact="migration" post="[31,32]. In addition, studies have indicated that CTSB and"/>
 <result pre="is inhibited by Pra-B as well as involved in the" exact="migration" post="and invasion of RCC cells. Therefore, CTSC and CTSV"/>
 <result pre="ligase NEDD4 interacted with EGFR, which mediated lung cancer cell" exact="migration" post="through activating CTSB [34]. The conclusions of the aforementioned"/>
 <result pre="with multiple activities, especially anticancer properties. Honokiol inhibited cancer cell" exact="migration" post="and invasion through downregulating EGFR phosphorylation [42]. In conjunction"/>
 <result pre="and CTSV expression are involved in Pra-B’s suppression of EGF-induced" exact="migration" post="and invasion in RCC cells. Currently, tyrosine kinase inhibitors"/>
 <result pre="Conflicts of Interest The authors declare that they have no" exact="conflict" post="of interest. The funders had no role in the"/>
 <result pre="promoting hepsin ubiquitin-proteasome degradationCancer Lett.201843810511510.1016/j.canlet.2018.09.02130227221 32.YangL.CuiM.ZhangL.SongL.FOXM1 facilitates gastric cancer cell" exact="migration" post="and invasion by inducing Cathepsin DOncotarget20178681806819010.18632/oncotarget.1925428978107 33.YangY.LimS.K.ChoongL.Y.LeeH.ChenY.ChongP.K.AshktorabH.WangT.T.Salto-TellezM.YeohK.G.et al.Cathepsin S"/>
 <result pre="inducing Cathepsin DOncotarget20178681806819010.18632/oncotarget.1925428978107 33.YangY.LimS.K.ChoongL.Y.LeeH.ChenY.ChongP.K.AshktorabH.WangT.T.Salto-TellezM.YeohK.G.et al.Cathepsin S mediates gastric cancer cell" exact="migration" post="and invasion via a putative network of metastasis-associated proteinsJ."/>
 <result pre="proteinsJ. Proteome Res.201094767477810.1021/pr101027g20812763 34.ShaoG.WangR.SunA.WeiJ.PengK.DaiQ.YangW.LinQ.The E3 ubiquitin ligase NEDD4 mediates cell" exact="migration" post="signaling of EGFR in lung cancer cellsMol. Cancer2018172410.1186/s12943-018-0784-229455656 35.ChenC.H.BhasinS.KhannaP.JoshiM.JoslinP.M.SaxenaR.AminS.LiuS.SindhuS.WalkerS.R.et"/>
 <result pre="independent experiments. Figure 2 Inhibitory effects of Pra-B on cell" exact="migration" post="and invasion of 786-0 and ACHN cell. (A) Cells"/>
 <result pre="h followed by the analysis of 786-0 and ACHN cell" exact="migration" post="and invasion by using an in vitro migration and"/>
 <result pre="ACHN cell migration and invasion by using an in vitro" exact="migration" post="and Matrigel-based invasion assay. (B) Quantification of migrating cells"/>
 <result pre="three independent experiments. Figure 5 Pra-B attenuated epidermal growth factor-induced" exact="migration" post="ability through the EGFR signaling pathway. The cells were"/>
 <result pre="10, 20, and 30 μM) for 24 h. (A) Cell" exact="migration" post="and invasion were measured using an in vitro migration"/>
 <result pre="Cell migration and invasion were measured using an in vitro" exact="migration" post="and Matrigel-based invasion assay. Quantification of migrating cells presented"/>
 <result pre="50 μm. Figure 6 Illustration of how Pra-B inhibits the" exact="migration" post="and invasion of human RCC cells through suppressing EGFR–MEK–ERK"/>
</results>
